ÅëÇÕ°Ë»ö
ƯÇãºÐ¼®º¸°í¼
±¹Á¦Æ¯ÇãºÐÀïÁöµµ
ƯÇãºÐ¼®µ¥ÀÌÅÍ
ºÐÀïÆÇ·ÊÁ¤º¸
ºÐÀï¿ë¾î»çÀü
/ ±¹Á¦Æ¯ÇãºÐÀïÁöµµ / ºÐÀïÆÇ·ÊÁ¤º¸ / ¹Ì±¹Æí
¹ý·üÀïÁ¡º° ÆÇ·Ê
ƯÇ㼺(Patentability) [204]
½Å±Ô¼º [70]
On-Sale Bar [15]
Public Use [8]
Experimental Use [3]
Anticipation [36]
Prior Invention [8]
ÀÚ¸í¼º [60]
Utility [3]
¸í¼¼¼ ±âÀç ¿ä°Ç [63]
¹ß¸íÀÚ ¿ä°Ç(Inventorship) [5]
ÀÌÁ߯¯Çã(Double Patenting) [3]
û±¸¹üÀ§Çؼ®(Claim Construction) [185]
û±¸¹üÀ§Çؼ® ÀÏ¹Ý [137]
Means plus Function Claim Language [25]
Intrinsic Evidence/Extrinsic Evidence [9]
Transitional Language [7]
ÇÑÁ¤¼º(Definiteness) [7]
ƯÇãÄ§ÇØ(Patent Infringement) [131]
ƯÇãÄ§ÇØÀÏ¹Ý [53]
±Õµî·Ð [27]
Ãâ¿ø°æ°ú ±Ý¹Ý¾ð(Prosecution History Estoppel) [25]
Á÷Á¢Ä§ÇØ [7]
°£Á¢Ä§ÇØ [11]
°íÀÇÄ§ÇØ(Willful Infringement) [8]
Equitable Defense,±¸Á¦¼ö´Ü ¹× ±âŸ [90]
Equitable Defense [32]
ºÒ°øÁ¤ÇàÀ§(Inequitable Conduct Before the PTO) [20]
ƯÇã±Ç³²¿ë(Patent Misuse)/µ¶Á¡±ÝÁö¼Ò¼Û(Antitrust Claim) [4]
ÇØÅÂ(Laches) [1]
±Ý¹Ý¾ð(Estoppel) [2]
ƯÇã¼ÒÁøÀÌ·Ð(Patent Exhaustion) [1]
Research Exception [4]
±¸Á¦¼ö´Ü [49]
±¸Á¦¼ö´Ü ÀÏ¹Ý [9]
Ä§ÇØ±ÝÁö¸í·É(Injunction) [24]
ƯÇãÇ¥½Ã/»ç½Ç»ó °íÁö(Marking, Notice) [1]
±ÝÀü¹è»ó(Monetary Damages) [9]
Extraterritorial Effect of Patents [5]
¿¬¹æÆ¯Çã¹ý ¿ì¼±Àû¿ë(Federal Patent Law Preemption) [1]
±âŸ [9]
Ownership [7]
ÀǾàǰƯÇãÁ¸¼Ó±â°£¿¬Àå [2]
-
ÁÂÃø Ç¥¿¡¼ ÁÖ¿ä "¹ý·üÀïÁ¡(ISSUE)"±×·ìÀÇ
¾ÆÀÌÄÜÀ» ¼±ÅÃÇϽøé, ÇØ´ç ¼ºê ¹ý·üÀïÁ¡ ±×·ìÀÌ
ÆîÃÄÁý´Ï´Ù.
-
¹ý·üÀïÁ¡¸íÀ̳ª ±×·ì¸íÀ» ¼±ÅÃÇÏ½Ã¸é °ü·Ã ISSUEº°
ºÐÀïÆÇ·Ê ¸ñ·ÏÀ» Á¶È¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.
SELECT
R&D ƯÇã¼¾ÅÍ
Çѱ¹¹ß¸íÁøÈïȸ
Çѱ¹Æ¯ÇãÁ¤º¸¿ø